Literature DB >> 22543623

A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.

Valentina Volynets1, Jürgen Machann, Markus A Küper, Ina B Maier, Astrid Spruss, Alfred Königsrainer, Stephan C Bischoff, Ina Bergheim.   

Abstract

PURPOSE: As a diet rich in fructose and an impaired intestinal barrier function have been proposed to be risk factors for the development of non-alcoholic fatty liver disease (NAFLD), the aim of the present pilot study was to determine whether a dietary intervention focusing on a reduction of fructose intake (-50 % in comparison with baseline) has a beneficial effect on liver status.
METHODS: A total of 15 patients with NAFLD were enrolled in the study of which 10 finished the study. Fructose and total nutrient intake were assessed using a diet history. At baseline and after 6 months liver status and markers of intestinal barrier function as well as plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma.
RESULTS: Hepatic lipid content and transaminases in plasma as well as body mass index and some parameters of glucose metabolism (e.g., fasting plasma insulin) were significantly lower at the end of the intervention when compared to baseline. Whereas the dietary intervention had no effect on the prevalence of bacterial overgrowth, orocecal transit time and the intestinal permeability or blood ethanol levels endotoxin and PAI-1 concentration in plasma were significantly lower at the end of 6 months intervention period than at baseline.
CONCLUSIONS: Taken together, our results indicate that a dietary intervention focusing only on one dietary parameter like fructose may help to decrease intrahepatic fat content of NAFLD patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543623     DOI: 10.1007/s00394-012-0355-z

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  31 in total

1.  Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.

Authors:  Giridhar Kanuri; Astrid Spruss; Sabine Wagnerberger; Stephan C Bischoff; Ina Bergheim
Journal:  Lab Invest       Date:  2011-03-21       Impact factor: 5.662

2.  Weight-loss with low or high carbohydrate diet?

Authors:  A Golay; C Eigenheer; Y Morel; P Kujawski; T Lehmann; N de Tonnac
Journal:  Int J Obes Relat Metab Disord       Date:  1996-12

Review 3.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

4.  Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy.

Authors:  Jürgen Machann; Claus Thamer; Birgit Schnoedt; Norbert Stefan; Hans-Ulrich Haring; Claus D Claussen; Andreas Fritsche; Fritz Schick
Journal:  Magn Reson Med       Date:  2006-04       Impact factor: 4.668

5.  Assessment of the reproducibility of the lactulose H2 breath test as a measure of mouth to caecum transit time.

Authors:  S J La Brooy; P J Male; A K Beavis; J J Misiewicz
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

6.  Increased orocecal transit time in patients with nonalcoholic fatty liver disease.

Authors:  Alejandro Soza; Arnoldo Riquelme; Robinson González; Manuel Alvarez; Rosa María Pérez-Ayuso; Juan Carlos Glasinovic; Marco Arrese
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

7.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

Authors:  Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

Review 8.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

9.  Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Authors:  Sabine Thuy; Ruth Ladurner; Valentina Volynets; Silvia Wagner; Stefan Strahl; Alfred Königsrainer; Klaus-Peter Maier; Stephan C Bischoff; Ina Bergheim
Journal:  J Nutr       Date:  2008-08       Impact factor: 4.798

10.  Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.

Authors:  Ashkan Farhadi; Sushama Gundlapalli; Maliha Shaikh; Constantine Frantzides; Laura Harrell; Mary M Kwasny; Ali Keshavarzian
Journal:  Liver Int       Date:  2008-04-07       Impact factor: 5.828

View more
  34 in total

Review 1.  Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

Authors:  Giulia Paolella; Claudia Mandato; Luca Pierri; Marco Poeta; Martina Di Stasi; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  Potential link between excess added sugar intake and ectopic fat: a systematic review of randomized controlled trials.

Authors:  Jiantao Ma; Micaela C Karlsen; Mei Chung; Paul F Jacques; Edward Saltzman; Caren E Smith; Caroline S Fox; Nicola M McKeown
Journal:  Nutr Rev       Date:  2015-10-29       Impact factor: 7.110

4.  [Liver volume, intrahepatic fat and body weight in the course of a lifestyle interventional study: Analysis with quantitative MR-based methods].

Authors:  M N Bongers; N Stefan; A Fritsche; H-U Häring; K Nikolaou; F Schick; J Machann
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

5.  Effect of Restriction of Foods with High Fructose Corn Syrup Content on Metabolic Indices and Fatty Liver in Obese Children.

Authors:  Lorena Del Rocio Ibarra-Reynoso; Hilda Lissette López-Lemus; Ma Eugenia Garay-Sevilla; Juan Manuel Malacara
Journal:  Obes Facts       Date:  2017-08-05       Impact factor: 3.942

Review 6.  Nonmedicinal interventions in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Radu M Nanau; Lawrence B Cohen
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

Review 7.  [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].

Authors:  S C Bischoff
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

Review 8.  Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease.

Authors:  Pietro Vajro; Giulia Paolella; Alessio Fasano
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-05       Impact factor: 2.839

9.  Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study.

Authors:  M Angeles Zulet; Itziar Abete; Cristina Galarregui; Irene Cantero; Bertha Araceli Marin-Alejandre; J Ignacio Monreal; Mariana Elorz; Alberto Benito-Boillos; José Ignacio Herrero; Víctor de la O; Miguel Ruiz-Canela; Helen Hermana M Hermsdorff; Josefina Bressan; Josep A Tur; J Alfredo Martínez
Journal:  Eur J Nutr       Date:  2020-08-28       Impact factor: 5.614

Review 10.  Dietary approach in the treatment of nonalcoholic fatty liver disease.

Authors:  Silvia Marinho Ferolla; Luciana Costa Silva; Maria de Lourdes Abreu Ferrari; Aloísio Sales da Cunha; Flaviano Dos Santos Martins; Cláudia Alves Couto; Teresa Cristina Abreu Ferrari
Journal:  World J Hepatol       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.